<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FT943-8384</title>
	</head>
	<body>
		<main>
			<p>940817 FT  17 AUG 94 / International Company News: Merck to sell two specialty subsidiaries Merck, the US pharmaceuticals group, plans to sell its specialty chemical units, Kelco and Calgon Vestal Laboratories, in order to focus resources on its integrated pharmaceutical and pharmacy benefits management business, AP-DJ reports. Merck declined to comment on the company's expectations for a price for the two units, but said Kelco and Calgon Vestal had combined sales of about Dollars 400m. The units could be sold together or separately, Merck said. It expects the process to be completed by the year-end.</p>
		</main>
</body></html>
            